TipRanks
Go Ultimate55% OFF

Compare Draegerwerk AG & Co. KGaA (DRW3) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
CH:DRW3Draegerwerk AG & Co. KGaACHF 106.60CHF 1.51B11.3079.16%―Unlock the CH:DRW3 analyst price target with TipRanks PremiumCH:DRW3Unlock the CH:DRW3 top-analyst price target with TipRanks Premium
DE:AFXCarl Zeiss MeditecEUR 34.78EUR 3.13B20.86-20.64%Moderate SellUnlock the DE:AFX analyst price target with TipRanks PremiumCH:DRW3 vs DE:AFXUnlock the DE:AFX top-analyst price target with TipRanks Premium
DE:COPCompuGroup MedicalEUR 28.45EUR 1.50B43.4216.12%―Unlock the DE:COP analyst price target with TipRanks PremiumCH:DRW3 vs DE:COPUnlock the DE:COP top-analyst price target with TipRanks Premium
DE:EUZEckert & Ziegler Strahlen und MedizintechnikEUR 13.37EUR 832.23M16.84-20.44%Moderate BuyUnlock the DE:EUZ analyst price target with TipRanks PremiumCH:DRW3 vs DE:EUZUnlock the DE:EUZ top-analyst price target with TipRanks Premium
DE:SBSSTRATEC BiomedicalEUR 23.90EUR 273.51M-598.751.91%Moderate BuyUnlock the DE:SBS analyst price target with TipRanks PremiumCH:DRW3 vs DE:SBSUnlock the DE:SBS top-analyst price target with TipRanks Premium
DE:SHLSiemens Healthineers AGEUR 43.52EUR 47.86B21.92-10.64%Strong BuyUnlock the DE:SHL analyst price target with TipRanks PremiumCH:DRW3 vs DE:SHLUnlock the DE:SHL top-analyst price target with TipRanks Premium

Performance Comparison

-50%-25%0%25%50%75%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
CH:DRW3Draegerwerk AG & Co. KGaA106.6047.1079.16%
DE:AFXCarl Zeiss Meditec34.84-7.21-17.15%
DE:COPCompuGroup Medical28.454.3017.83%
DE:EUZEckert & Ziegler Strahlen und Medizintechnik13.47-2.92-17.84%
DE:SBSSTRATEC Biomedical23.951.777.97%
DE:SHLSiemens Healthineers AG43.40-4.27-8.96%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts